Customer Center
Login | Register

Investor Relations

  • Banner Image

News Releases

Date Title  
Toggle Summary Luminex Corporation Reports First Quarter 2019 Financial Results
AUSTIN, Texas , May 6, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ:LMNX) today announced financial results for the first quarter 2019.  Financial and operating highlights for the quarter include: First quarter consolidated revenue of $82.4 million compared to the first quarter 2018 revenue of
Toggle Summary Luminex Corporation First Quarter Earnings Release Scheduled for May 6, 2019
AUSTIN, Texas , April 18, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the first quarter ended March 31, 2019 on Monday, May 6, 2019 . A press release announcing the results is scheduled for release after the close of trading on that
Toggle Summary Luminex Corporation to Present at the Barclays Global Healthcare Conference
AUSTIN, Texas , March 5, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Barclays Global Healthcare Conference to be held March 12-14, 2019 , in Miami . The fireside chat will begin at 9:30 a.m. Eastern time on Tuesday, March 12, 2019 .
Toggle Summary Luminex Corporation Declares First Quarter Cash Dividend
AUSTIN, Texas , Feb. 8, 2019 /PRNewswire/ --   Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the first quarter of 2019 of $0.06 per share of common stock payable on April 11 , 2019 to stockholders of record as of the
Toggle Summary Luminex Corporation Reports Fourth Quarter and Full-Year 2018 Financial Results
AUSTIN, Texas , Feb. 4, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full-year 2018.  Financial and operating highlights for the quarter and full-year include: On December 31, 2018 , the Company closed the acquisition of EMD
Toggle Summary Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2018; Company to Present at 37th Annual J.P. Morgan Healthcare Conference
AUSTIN, Texas , Jan. 7, 2019 /PRNewswire/ --  Luminex Corporation (Nasdaq: LMNX) today announced that it expects its revenues in the fourth quarter of 2018 to be approximately $81 million and to exceed $315 million for the full- year ended 2018, near the top of the previously communicated guidance
Toggle Summary Luminex Corporation Completes Acquisition of MilliporeSigma's Flow Cytometry Portfolio
AUSTIN, Texas , Jan. 2, 2019 /PRNewswire/ --  Luminex Corporation (NASDAQ: LMNX) today announced that the company has completed its previously announced acquisition of MilliporeSigma's flow cytometry portfolio for $75 million in combined stock, asset and inventory purchases.